Latest News & Updates
Breaking News
2 hours ago
Simantini Singh Deo
Other trending news you may like to read
Alkem Launches DCGI-Approved Semaglutide Pre-Filled Syringes in India at Rs. 350 Per Dose
Alkem launches DCGI-approved semaglutide pre-filled syringes at Rs. 350, raising fill-finish, cold-chain, and regulatory compliance questions for Indian GLP-1 manufacturers.
Simantini Singh Deo
Cipla Appoints Taher Karampurwala as Senior Director to Head Middle East Business
Cipla relocates a senior executive to Saudi Arabia to lead Middle East operations, signalling deeper regulatory and commercial commitment across Gulf markets.
Simantini Singh Deo
AB Science Advances Masitinib ALS Phase 3 Trial as AB8939 Emerges as Second Pipeline Pillar
AB Science's FDA-authorized ALS Phase 3 trial and AML programme advance as Stonegate assigns €4.25/share DCF valuation.
Simantini Singh Deo
Sapience Therapeutics Achieves Phase 2 Milestone for Lucicebtide in Newly Diagnosed Glioblastoma
Sapience Therapeutics releases Phase 2 data for lucicebtide plus chemoradiation in newly diagnosed GBM, covering efficacy, pharmacodynamics, and safety.
Vaibhavi M.
